GENOME ANNOUNCEMENT
===================

The obligate intracellular bacterium *Chlamydia trachomatis* is the major cause of bacterial sexually transmitted infections worldwide and is also responsible for trachoma, the leading infectious cause of blindness. Trachoma results from a conjunctival chronic inflammatory state leading to the formation of irreversible corneal opacities and blindness ([@B1], [@B2]). It is one of 17 neglected tropical diseases and is targeted for elimination by 2020 by the World Health Organization (WHO) through the implementation of the SAFE strategy: lid surgery (S), antibiotics to treat the infection (A), facial cleanliness (F), and environmental changes (E) ([@B3]). Trachoma affects about 2.2 million people and it is endemic in \>50 countries, predominantly in sub-Saharan Africa, the Middle East, and Asia ([@B2]). This epidemiological pattern is essentially associated with *C. trachomatis* ocular serovars A and B ([@B4]) (from the existent 15 major serovars), whereas serovar C seems relatively common in indigenous Australian communities ([@B5], [@B6]). Of note, serovar C has been also associated with *Chlamydia*-related arthritis ([@B7]). There are already five and two annotated genomes from serovars A and B ([@B8]--[@B10]), respectively. We report here the first complete and annotated sequence of a trachoma-causing *C. trachomatis* serovar C strain, TW-3.

The C/TW-3 strain was isolated in Taiwan in 1959 from the human conjunctiva ([@B11]). We obtained this strain from the American Type Culture Collection (ATCC VR-1477) and propagated it in HeLa229 cell monolayers before proceeding with bacterial purification using discontinuous urographin density gradients ([@B12]). The whole-genome sequence was determined by using a paired-end strategy (2 × 250 bp) with the platform Illumina MiSeq. The reads were mapped to *C. trachomatis* chromosome and plasmid sequences ([@B8]--[@B10]) using both Bowtie 2 (version 2.1.0 \[<http://bowtie-bio.sourceforge.net/bowtie2/index.shtml>\]) ([@B13]) and the Burrows-Wheeler Aligner (BWA) software (version 0.7.5a \[<http://bio-bwa.sourceforge.net/>\]) ([@B14]). Globally, 5,233,958 reads (with a mean quality score \>30 for \>95% of the read bases) were mapped, which yielded a mean coverage of 1,117-fold and 6,717-fold for the chromosome and plasmid, respectively. Single-nucleotide polymorphisms (SNPs) and indels were identified using SAMtools, followed by variant calling using BCFtools (<http://samtools.sourceforge.net/>) ([@B15]), and were carefully inspected through the Integrative Genomics Viewer (version 2.3.12 \[<http://www.broadinstitute.org/igv/>\]) ([@B16]). Both the typing gene (*ompA*) and problematic regions (e.g., *tarP*) were confirmed by PCR, followed by Sanger sequencing. The sequence was annotated by the NCBI Prokaryotic Genomes Annotation Pipeline 2.3.

The genome sequence of C/TW-3 revealed a chromosome of 1,043,554 bp in length, with a G+C content of 41.30% and 922 predicted coding sequences (CDSs). Plasmid analysis revealed the existence of about six copies per chromosome (based on the ratio of mean coverage for plasmid/chromosome), which fits with previous data ([@B17]), and the plasmid was found to be 7,501 bp in length, comprising eight CDSs (G+C content of 36.25%).

The availability of a complete and annotated genome sequence of an additional trachoma-causing serovar may contribute to the elucidation of the genetic basis underlying the pathogenic differences between *C. trachomatis* ocular strains ([@B7], [@B18], [@B19]).

Nucleotide sequence accession numbers. {#h1}
--------------------------------------

The complete genome sequence of *C. trachomatis* serovar C (strain TW-3) has been assigned GenBank accession no. [CP006945](http://www.ncbi.nlm.nih.gov/nuccore?term=CP006945) (chromosome) and [CP006946](http://www.ncbi.nlm.nih.gov/nuccore?term=CP006946) (plasmid).
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